SOLAR-PROMOTION
28.5.2024 10:42:32 CEST | Business Wire | Press release
Visitors to The smarter E Europe, Europe’s Largest Alliance of Exhibitions for the Energy Industry, will find out how private consumers can become self-sufficient in electricity, heat and transport in a smart way and how this creates new business opportunities for installers and system providers. The smarter E Europe combines the four trade fairs Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe and takes place from June 19 to 21 at Messe München. Around 3,000 exhibitors and more than 115,000 visitors from all over the world are expected in 19 exhibition halls and on an outdoor area.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240528827105/en/
The smarter E Europe shows interplay of components. ©Solar Promotion GmbH
There are around 19.3 million residential buildings in Germany. More than half of these will need to be renovated and equipped with photovoltaics over the next 20 years. But residential buildings also play a central role in solar expansion throughout Europe. Everywhere, solar systems are being installed with storage systems, as this allows the solar power generated to be used as needed.
Increasing electrification in the transport and heating sectors
Solar power has been generated and stored to supply the home, but what else can it be used for? For the increasingly popular electric car. In the home system, battery electric vehicles as well as heat pumps can be charged and operated cost-effectively and climate-neutrally with the solar power. In Germany, 51 percent more heat pumps were sold last year than in 2022. With the adoption of the EU Heat Pump Action Plan, this development will continue dynamically. The combination of PV, a storage system, electric car and heat pump forms an effective network of electricity-generating, electricity-storing and electricity-consuming units.
An interplay of components and trade disciplines
The industry offers a wide range of components - from PV systems and intelligent wall boxes to smart meters and much more. However, successfully building a comprehensive energy system requires not only interaction between the individual components, but also smooth cooperation between the electrical trade, plumbing, heating and air conditioning technology (HVAC) and other trades.
Optimize self-consumption, relieve the grid
The electricity system requires a high degree of flexibility in order to be able to provide a renewable energy supply 24/7. Flexible small consumers with their own home energy systems can make a major contribution to keeping electricity generation and consumption in balance while optimizing their own consumption at low cost.
Dynamic electricity tariffs: Supply meets demand
Dynamic electricity tariffs are another way of better coordinating supply and demand. Consumers base their consumption on the current electricity prices, which change depending on supply and demand. From 2025, all electricity suppliers in Germany will be obliged to offer their customers a dynamic electricity tariff. Prerequisite for this is the installation of a smart meter.
The smarter E Europe
"Accelerating Integrated Energy Solutions" - under this motto, The smarter E Europe, Europe's largest trade fair alliance for the energy industry, focuses on cross-industry solutions for a 24/7 renewable energy supply in the electricity, heating and transport sectors. The smarter E Europe combines four trade fairs and will take place from June 19-21, 2024 at Messe München.
Further information: www.TheSmarterE.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528827105/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom